Narendranath Epperla

110PUBLICATIONS
406CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (110)

|Jul 25, 2026
Cardiovascular Toxicity Associated With Bispecific Antibodies in Hematological Malignancies: A Comprehensive Pharmacovigilance Analysis.

|Jul 23, 2026
Identifying the angiogenic receptor expression in mantle cell lymphoma patients and murine models.

|Jul 14, 2026
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22.

|Jul 08, 2026
Identification of an optimal absolute lymphocyte count at leukapheresis in patients with lymphoma treated with CART.

|Jun 18, 2026
Real-world outcomes of bispecific antibody therapy after chimeric antigen receptor T-cell therapy in follicular lymphoma.

|Jun 09, 2026
Prognostic factors and survival outcomes in relapsed/refractory aggressive B-cell lymphomas treated with epcoritamab.

Pageof 19

Frequent Collaborators

21 joint publications

Reem Karmali

15 joint publications

Timothy Voorhees

14 joint publications

Mehdi Hamadani

13 joint publications

Natalie S Grover